Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Pharmacology|March 23, 1993
Characterisation of a novel, selective radioligand, [125I][Lys5,Tyr(I2)7,MeLeu9,Nle10]neurokinin A-(4-10), for the tachykinin NK2 receptor in rat fundusE Burcher, T Badgery-Parker, X P Zeng, et al.
Clinical and Experimental Pharmacology & Physiology|November 9, 2000
Circular muscle contraction, messenger signalling and localization of binding sites for neurokinin A in human sigmoid colonF J Warner, L Liu, D Z Lubowski, et al.
Peptides|October 24, 1998
Purification, characterization, and spasmogenic activity of neurotensin from the toad Bufo marinusF J Warner, E Burcher, R Carraway, et al.
European Journal of Pharmacology|August 26, 1998
An investigation of tachykinin NK2 receptor subtypes in the ratM A Matuszek, X P Zeng, J Strigas, et al.
Peptides|July 1, 1993
Receptor binding profile of neuropeptide gamma and its fragments: comparison with the nonmammalian peptides carassin and ranakinin at three mammalian tachykinin receptorsT Badgery-Parker, S Lovas, J M Conlon, et al.
Regulatory Peptides|July 2, 1993
A novel, selective radioligand, [125I]-[Lys5,Tyr(I2)7,MeLeu9,Nle10]-NKA(4-10), for the tachykinin NK-2 receptorT Badgery-Parker, X P Zeng, S Lavielle, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 24, 1999
Pharmacological and biochemical investigation of receptors for the toad gut tachykinin peptide, bufokinin, in its species of originL Liu, F J Warner, J M Conlon, et al.
Acta Pharmacologica Et Toxicologica|August 1, 1977
Actions of neurotensin and (Gln4)-neurotensin on isolated tissuesA Rökaeus, E Burcher, D Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1986
Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladderE Burcher, S H Buck, W Lovenberg, et al.
Neuropeptides|October 1, 1991
Neuropeptide gamma, the most potent contractile tachykinin in human isolated bronchus, acts via a 'non-classical' NK2 receptorE Burcher, L A Alouan, P R Johnson, et al.
Pageof 11